Inhibition of monocyte recruitment by blocking the CCL2 and CCR2 signaling pathways reduces excessive inflammation, myocardial infarction and atherosclerosis is protective in a sclerosis-like mouse model (Tsou et al., 2007). Here, CCR2 is linked to myocardial infarction.